Aspects of the present disclosure relate to binding agents (e.g., antibodies and antigen binding fragments) that bind soluble fms-like tyrosine kinase 1 (sFlt1) in an isoform specific manner. In some embodiments, immunological assay methods utilizing isoform-specific antibodies or antigen binding fragments that bind sFlt1 isoforms are provided for assessing biological samples obtained from pregnant subjects, e.g., for purposes of evaluating preeclampsia status in the subject.

pre-eclampsia/tyrosine

Isoform specific soluble FMS-like tyrosine kinase (sFlt) binding agents and uses thereof

Најкомплетнија база лековитог биља подржана науком